NeoGenomics, Inc.: NeoGenomics Announces CEO Departure and Initiates CEO Search : vimarsana.com

Board Appoints Executive Chair and Interim Office of the CEOAnticipates First Quarter Results Below Guidance and Withdraws 2022 GuidanceFT. MYERS, FL / ACCESSWIRE / March 28, 2022 / NeoGenomics, Inc. (NASDAQ:NEO)

Related Keywords

Fort Myers , Florida , United States , Georgia , Tampa , North Carolina , United Kingdom , Texas , Kellogg School , California , Research Triangle Park , Atlanta , University Of Florida , San Diego , Arizona , Tennessee , Singapore , Phoenix , Aliso Viejo , Houston , Cambridge , Cambridgeshire , Switzerland , Charlie Eidson , William Bonello , Mark Mallon , Karen Chandler Smith , Lynn Tetrault , Douglas Brown , Russell Reynolds , Inivata Invision , Jennifer Balliet , Doug Brown , Cancer Research United Kingdom Cambridge Institute , Carleton College , Nasdaq , Company Annual Report On Form , University Of Cambridge , Kellogg School Of Management At Northwestern University , Clinical Services , Genoptix , Piper Jaffray , Neogenomics Inc , Princeton University , Fuqua School Of Business At Duke University , Rhythm Pharmaceuticals , Company Pharma Services Division , Wachovia Securities , Craig Hallum Capital Group , University Of Texas At Austin , University Of Virginia Law School , Corporate Development , Corporate Affairs , Consilium Strategic Communications , Board Appoints Executive Chair , Interim Office , First Quarter Results Below Guidance , Chief Executive Officer , Chair Lynn Tetrault , Executive Chair , Chief Financial Officer , Chief Strategy , Corporate Development Officer , Chief Culture Officer , Board Member , Lead Independent Director , Non Executive Chair , Executive Vice President , Human Resources , Non Executive Director , Virginia Law , Craig Hallum Capital , Senior Vice President , Investor Relations , Senior Managing Director , Corporate Financing , General Electric , Fuqua School , Duke University , Vice President , Business Management , Pharma Services Division , Privacy Practices , Breakthrough Device Designation , Annual Report , Media Contacts , Neogenomics , Nnounces , Eparture , Nitiates , Earch ,